A 2nd annual International Pharmaceutical Distribution Conference is set for November
HDMA brings GIRP and IFPW together in Brussels
Following its successful first international meeting last year in China, this year the Healthcare Distribution Management Assn. is going to Europe—Brussels, Belgium to be specific, for a second international meeting, to be held on Nov. 12-13. Like its domestic Distribution Management conference in the US, the meeting showcases technologies and business practices to elevate distribution practices.
HDMA will be joined by GIRP (the European Assn. of Pharmaceutical Full-line Wholesalers) and IFPW, the International Federation of Pharmaceutical Wholesalers. Program topics will include pharmaceutical traceability and verification systems; the impact of international trade agreements; and building collaborative supply chain partnerships, says HDMA.
“As many pharmaceutical distributors and manufacturers look outside the U.S. to expand their portfolios and gain ideas to strategically build their businesses internationally, HDMA is continuing its efforts to bring together supply chain leaders from around the world to understand the opportunities and challenges of an increasingly globalized industry,” said HDMA president and CEO John Gray.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.
